Cardiovascular disease complications in systemic lupus erythematosus (Q43061600)

13 November 2017

title

Cardiovascular disease complications in systemic lupus erythematosus (English)

1 reference

13 November 2017

main subject

cardiovascular disease

1 reference

Alexander Torres

1

1 reference

13 November 2017

Ali D Askari

series ordinal

2

1 reference

13 November 2017

Charles J Malemud

series ordinal

3

1 reference

13 November 2017

publication date

1 June 2009

1 reference

13 November 2017

published in

Biomarkers in Medicine

1 reference

13 November 2017

volume

3

1 reference

13 November 2017

issue

3

1 reference

13 November 2017

page(s)

239-252

1 reference

Atherosclerosis is an inflammatory disease

13 November 2017

cites work

1 reference

Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium

21 January 2018

1 reference

New therapies for systemic lupus erythematosus: cellular targets

21 January 2018

1 reference

The bimodal mortality pattern of systemic lupus erythematosus

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

21 January 2018

1 reference

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis

21 January 2018

1 reference

Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

Cardiovascular morbidity and mortality in rheumatoid arthritis

21 January 2018

1 reference

The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients

21 January 2018

1 reference

Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility

21 January 2018

1 reference

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

21 January 2018

1 reference

FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity

21 January 2018

1 reference

The genetics and biology of Irf5-mediated signaling in lupus

21 January 2018

1 reference

A compass that points to lupus: genetic studies on type I interferon pathway.

21 January 2018

1 reference

Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake

21 January 2018

1 reference

Increased soluble FcgammaRIIIa(Mphi) in plasma from patients with coronary artery diseases

21 January 2018

1 reference

Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism

21 January 2018

1 reference

Genetic variants of TNFSF4 and risk for carotid artery disease and stroke.

21 January 2018

1 reference

Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus

21 January 2018

1 reference

Inflammation: a pivotal link between autoimmune diseases and atherosclerosis

21 January 2018

1 reference

Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis

21 January 2018

1 reference

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

21 January 2018

1 reference

Endothelial dysfunction of peripheral arteries in patients with immunohistologically confirmed myocardial inflammation correlates with endothelial expression of human leukocyte antigens and adhesion molecules in myocardial biopsies

21 January 2018

1 reference

Mechanisms of dyslipoproteinemias in systemic lupus erythematosus

21 January 2018

1 reference

Systemic lupus erythematosus, atherosclerosis, and autoantibodies

21 January 2018

1 reference

Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association

21 January 2018

1 reference

Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis?

21 January 2018

1 reference

The role of CD40 ligand in systemic lupus erythematosus

21 January 2018

1 reference

Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells

21 January 2018

1 reference

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

21 January 2018

1 reference

Angiogenesis: update 2005.

21 January 2018

1 reference

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

21 January 2018

1 reference

Corneal avascularity is due to soluble VEGF receptor-1

21 January 2018

1 reference

Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis

21 January 2018

1 reference

Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells.

21 January 2018

1 reference

VEGF secretion by macrophages is stimulated by lipid and protein components of OxLDL via PI3-kinase and PKCzeta activation and is independent of OxLDL uptake

21 January 2018

1 reference

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease

21 January 2018

1 reference

Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study).

21 January 2018

1 reference

Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis

21 January 2018

1 reference

Circulating markers of inflammation and atherosclerosis

21 January 2018

1 reference

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes

21 January 2018

1 reference

The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

21 January 2018

1 reference

Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients.

21 January 2018

1 reference

Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management

21 January 2018

1 reference

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

Change in and predictors of leisure activities among patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks

21 January 2018

1 reference

The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress

21 January 2018

1 reference

Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?

21 January 2018

1 reference

Unraveling pleiotropic effects of statins on plaque rupture

21 January 2018

1 reference

Therapy with statins in patients with refractory rheumatic diseases: a preliminary study

21 January 2018

1 reference

Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus.

21 January 2018

1 reference

T-lymphocyte signalling in systemic lupus erythematosus: a lipid raft perspective

21 January 2018

1 reference

Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus

21 January 2018

1 reference

Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus

21 January 2018

1 reference

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

21 January 2018

1 reference

Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

Bosentan use in systemic lupus erythematosus patients with pulmonary arterial hypertension

21 January 2018

1 reference

The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study

21 January 2018

1 reference

Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus

21 January 2018

1 reference

Lipid rafts: cell surface platforms for T cell signaling

21 January 2018

1 reference

Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction

21 January 2018

1 reference

Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.09.14

1 reference

13 November 2017

1 reference